Grand Rapids Deaf and Hard of Hearing Services to host COVID-19 vaccine clinic fox17online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fox17online.com Daily Mail and Mail on Sunday newspapers.
Michigan Medicine opens COVID-19 long haul clinics for adult, pediatric patients
Meredith Bruckner, Community News Producer, All About Ann Arbor
Published:
Updated:
Tags:
Pediatric specialists at C.S. Mott Children s Hospital. (Michigan Medicine)
ANN ARBOR – Michigan Medicine announced it is establishing clinics to provide care for patients experiencing post-COVID symptoms and complications, known as “long-haulers.”
These are adult and pediatric patients that continue to experience multi-organ long-term issues including cardiovascular, kidney, metabolic, mood, pulmonary and neurologic complications.
Recently, data has revealed that patients who only experienced mild COVID-19 cases still have a high risk of developing lasting complications.
More than 1,500 adults have been hospitalized at Michigan Medicine with severe COVID-19 and more than 60 percent of them have diabetes. Doctors at C.S. Mott Children’s Hospital have also reported more than a dozen cases of
Although there isn’t enough research to determine who is most at risk, the clinic said the average patient is in their 40s, and they tend to see more women than men.
Even healthy people with mild infections have been hit hard with lingering symptoms, including shortness of breath, nerve pain, fatigue, headaches and the loss of taste and smell, according to infectious disease expert Dr. Hana Akselrod.
“People who initially were not hospitalized and had mild or moderate illness to begin with, but then continue to experience fairly profound and debilitating symptoms,” Akselrod said.
Across the country, clinics like the one at George Washington University Hospital are starting to launch to help patients with long-lasting symptoms recover.
Clinic at UVA using antibody treatment to prevent severe COVID-19 UVA Health (FILE) (Source: WVIR) By Rachel Hirschheimer | April 20, 2021 at 5:24 PM EDT - Updated April 20 at 10:04 PM
CHARLOTTESVILLE, Va. (WVIR) - A new antibody treatment has now been authorized by the Food and Drug Administration to prevent the progression of the coronavirus. Now, one doctor at the University of Virginia is working to administer this life saving drug to patients in the COVID Clinic.
“We were able to set up a program right within our clinic to help administer them, and that program has been going really well,” Dr. Debbie-Ann Shirley, director of the COVID Clinic at UVA, said.